Dergiler / Eurasian Journal of Emergency Medicine / 2019 / Cilt: 18 - Sayı: 4

A Retrospective Study: When Should We Give Antibiotics to Patients with Febrile Neutropenia in the Emergency Department?

Sayfa
192–196
Yayın Tarihi
2022-10-11
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In the logistic regression analysis, the probability of death at the end of the first month in patients who hadantibiotic administration >6 hours was found 2.436 times higher than the other group.Conclusion: As a result, we found that the administration of the first dose of antibiotics to f FN patients in the first 6 hours is effective inreducing mortality.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: Febrile neutropenia (FN) is considered to be one of the most important and potentially life-threatening oncologic diseases in theemergency department.
📊
Temel Bulgular & Veri:The study population consisted of FN patients who hadmalignancy >18 years and were admitted to the university hospital between January 2002 and July 2014.
💡
Sonuç & Katkı:In the logistic regression analysis, the probability of death at the end of the first month in patients who hadantibiotic administration >6 hours was found 2.436 times higher than the other group.Conclusion: As a result, we found that the administration of the first dose of antibiotics to f FN patients in the first 6 hours is effective inreducing mortality.
🔬Tür:Araştırma Makalesi
📍Kapsam:2002 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Aim: Febrile neutropenia (FN) is considered to be one of the most important and potentially life-threatening oncologic diseases in theemergency department. Our study aimed to determine whether there is an effective time for decreasing the mortality at the end of thefirst month after antibiotic administration.Materials and Methods: This study was designed as a retrospective cohort study. The study population consisted of FN patients who hadmalignancy >18 years and were admitted to the university hospital between January 2002 and July 2014. A total of 645 patients wereincluded in the study. Of the patients, 322 patients were included in the analysis. The cut-off value for antibiotic administration wasdetermined as ≤6 hours vs >6 hours.Results: The median age was 54 years, and 173 (53.7%) of the patients were male. Hematological and lung malignancies were found mostfrequently (46.9%, 12.4%, respectively). The median value of antibiotic administration was 247 minutes, and the mortality rate at the endof the first month was 24.5%. In the logistic regression analysis, the probability of death at the end of the first month in patients who hadantibiotic administration >6 hours was found 2.436 times higher than the other group.Conclusion: As a result, we found that the administration of the first dose of antibiotics to f FN patients in the first 6 hours is effective inreducing mortality.

🔖

Bu Makaleye Atıf Yap

KORKUT, M., AVCI, A., SÖYÜNCÜ, S., BEKTAŞ, F. (2022). A Retrospective Study: When Should We Give Antibiotics to Patients with Febrile Neutropenia in the Emergency Department?. Eurasian Journal of Emergency Medicine, Cilt: 18 - Sayı: 4, 192–196. https://ajindex.com/articles/508022

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Courtney DM, Aldeen AZ, Gorman SM, Handler JA, Trifilio SM, Parada JP, et al. Cancer-Associated Neutropenic Fever: Clinical Outcome and Economic Costs of Emergency Department Care. Oncologist. 2007;12:1019-26
  2. Netterberg I, Karlsson MO, Nielsen EI, Quartino AL, Lindman H, Friberg LE. The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin-6 and C-reactive protein by modelling. Br J Clin Pharmacol. 2018;84:490-500
  3. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Executive Summary: Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52:427-31
  4. Dang A, Gjolaj LN, Whitman M, Fernandez G. Using Process Improvement Tools to Improve the Care of Patients With Neutropenic Fever in the Emergency Room. J Oncol Pract. 2018;14:e73-81
  5. Lee SJ, Kim JH, Han SB, Paik JH, Durey A. Prognostic Factors Predicting Poor Outcome in Cancer Patients with Febrile Neutropenia in the Emergency Department: Usefulness of qSOFA. J Oncol. 2018;2018:1-7
  6. Nirenberg A, Mulhearn L, Lin S, Larson E. Emergency Department Waiting Times for Patients With Cancer With Febrile Neutropenia: A Pilot Study. Oncol Nurs Forum. 2004;31:711-5
  7. Lin MY, Weinstein RA, Hota B. Delay of Active Antimicrobial Therapy and Mortality among Patients with Bacteremia: Impact of Severe Neutropenia. Antimicrob Agents Chemother. 2008;52:3188-94
  8. Wingard JR, Elmongy M. Strategies for minimizing complications of neutropenia: Prophylactic myeloid growth factors or antibiotics. Crit Rev Oncol Hematol. 2009;72:144-54
  9. Legrand M, Max A, Peigne V, Mariotte E, Canet E, Debrumetz A, et al. Survival in neutropenic patients with severe sepsis or septic shock*. Crit Care Med. 2012;40:43-9
  10. Flowers CR, Seidenfeld J, Bow EJ, Karten C, Gleason C, Hawley DK, et al. Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2013;31:794-810
  11. Perrone J, Hollander JE, Datner EM. Emergency Department evaluation of patients with fever and chemotherapy-induced neutropenia. J Emerg Med. 2004;27:115-9
  12. Nasr ZG, Abu Yousef S, Jibril F, Wilby KJ. Critical appraisal of clinical practice guidelines for adult cancer patients with febrile neutropenia. I